“…TCDD is known to activate the EGFR-ERK pathway and accelerate epithelial differentiation (Hansen et al, 1997, Sibilia and Wagner, 1995, Sutter et al, 2011, Kennedy et al, 2013, Sutter et al, 2020, Sutter et al, 2023, Fernandez-Salguero et al, 1996, Puga et al, 2005, Choi et al, 2006, Patel et al, 2006), an effect that may lead to promotion of precocious eyelid opening in postpartum pups (Theobald and Peterson, 1997, Gray et al, 1997, Miettinen et al, 2004, Dominey et al, 1993) and development of chloracne, a hyperkeratotic skin disorder, found in humans exposed to high dose TCDD (Sutter et al, 2011, Muenyi et al, 2014, Loertscher et al, 2001). This effect of TCDD, however, is insufficient to block embryonic lid closure.…”